# Translational Validation Study to Examine KFO179-1 Biomarker Scores for the Prediction and Prognosis of Advanced Primary Resectable Rectal Cancer Stages UICC-II-IV, With a 5-Fluorouracil-based Standard Radiochemotherapy Followed by Total Mesorectal Excision.

> **NCT03034473** · NA · UNKNOWN · sponsor: **University Medical Center Goettingen** · enrollment: 200 (actual)

## Conditions studied

- Locally Advanced Rectal Cancer

## Interventions

- **OTHER:** Translational Research and multimodal treatment

## Key facts

- **NCT ID:** NCT03034473
- **Lead sponsor:** University Medical Center Goettingen
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-08
- **Primary completion:** 2024-08
- **Final completion:** 2024-08
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2023-12-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03034473

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03034473, "Translational Validation Study to Examine KFO179-1 Biomarker Scores for the Prediction and Prognosis of Advanced Primary Resectable Rectal Cancer Stages UICC-II-IV, With a 5-Fluorouracil-based Standard Radiochemotherapy Followed by Total Mesorectal Excision.". Retrieved via AI Analytics 2026-08-17 from https://api.ai-analytics.org/clinical/NCT03034473. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*